Doctor profile · Federal record
Dr. Mark Benjamin, M.D.
Specialist · Philadelphia, PA
- NPI 1992760185
- 20 yrs on file
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
9501 Roosevelt Blvd, Suite #208
Philadelphia, PA 191141025
(215) 969-2300
fax (215) 969-2327
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Pennsylvania #MD026817E
- Medicaid (2)
- PA #0065803 · PA #0907010
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1992760185. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
382
Distinct HCPCS
6
Medicare allowed
$39,628
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 174 | 92 | $81 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 105 | 76 | $132 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 57 | 53 | $134 | |
94010 |
Test to measure expiratory airflow and volume | 19 | 18 | $28 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 16 | 16 | $173 | |
94726 |
Test to determine lung volumes using sensors | 11 | 11 | $57 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 105. This provider delivers 3.6× the peer median.Open Payments
Industry payments received
All-time total
$1,138
Transactions
43
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $560.19 | |
| GlaxoSmithKline, LLC. | 12 | $182.27 | |
| HARMONY BIOSCIENCES LLC | 4 | $155.89 | |
| JAZZ PHARMACEUTICALS INC. | 3 | $111.77 | |
| Avadel CNS Pharmaceuticals, LLC | 2 | $53.52 | |
| Harmony Biosciences Llc | 1 | $41.49 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $18.27 | |
| Amgen Inc. | 1 | $14.38 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
563
Patients
58
Total drug cost
$211,757
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 118 | 19 | $86,299 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 111 | 23 | $3,497 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 64 | 0 | $32,079 |
| Spiriva Handihaler (Tiotropium Bromide) | Brand | 38 | 0 | $20,627 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 36 | 0 | $16,189 |
| Prednisone | Generic | 33 | 16 | $243 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 29 | 0 | $27,276 |
| Budesonide-Formoterol Fumarate (Budesonide/Formoterol Fumarate) | Brand | 25 | 0 | $7,215 |
| Montelukast Sodium | Generic | 22 | 0 | $177 |
| Novolog Flexpen (Insulin Aspart) | Brand | 17 | 0 | $2,057 |
Frequently asked questions
What is Dr. Mark Benjamin's medical specialty?
Dr. Mark Benjamin practices Specialist in Philadelphia, PA.
Where does Dr. Mark Benjamin practice?
Dr. Mark Benjamin practices at 9501 Roosevelt Blvd, Philadelphia, PA 191141025. Office phone: 2159692300.
What is Dr. Mark Benjamin's NPI?
Dr. Mark Benjamin's National Provider Identifier (NPI) is 1992760185, issued by NPPES.
What procedures does Dr. Mark Benjamin commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Established patient office or other outpatient visit (HCPCS 99214); Initial hospital care with straightforward or low-level medical decision making (HCPCS 99222). Source: CMS Medicare Physician & Other Practitioners file.